Loading...
XNYS
A
Market cap41bUSD
Dec 05, Last price  
145.49USD
1D
-1.91%
1Q
13.00%
Jan 2017
219.34%
Name

Agilent Technologies Inc

Chart & Performance

D1W1MN
XNYS:A chart
P/E
32.00
P/S
6.34
EPS
4.55
Div Yield, %
0.49%
Shrs. gr., 5y
-1.76%
Rev. gr., 5y
4.75%
Revenues
6.51b
-4.73%
5,139,000,0004,973,000,0005,420,000,0005,774,000,0004,481,000,0005,444,000,0006,615,000,0006,858,000,0006,782,000,0006,981,000,0004,038,000,0004,202,000,0004,472,000,0004,914,000,0005,163,000,0005,339,000,0006,319,000,0006,848,000,0006,833,000,0006,510,000,000
Net income
1.29b
+3.95%
327,000,0003,307,000,000638,000,000693,000,000-31,000,000624,000,0001,012,000,0001,153,000,000724,000,000497,000,000398,000,000460,000,000684,000,000316,000,0001,071,000,000719,000,0001,210,000,0001,254,000,0001,240,000,0001,289,000,000
CFO
1.75b
-1.19%
899,000,000634,000,000969,000,000756,000,000408,000,000712,000,0001,260,000,0001,228,000,0001,152,000,000713,000,000491,000,000793,000,000889,000,0001,087,000,0001,021,000,000921,000,0001,485,000,0001,312,000,0001,772,000,0001,751,000,000
Dividend
Oct 01, 20240.236 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
IPO date
Nov 18, 1999
Employees
18,300
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑042024‑102023‑102022‑102021‑102020‑102019‑102018‑102017‑102016‑10
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT